Insider Transactions in Q4 2024 at Skye Bioscience, Inc. (SKYE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Tuan Tu Diep Chief Development Officer |
SELL
Open market or private sale
|
Direct |
19,489
-19.15%
|
$77,956
$4.99 P/Share
|
|
Nov 18
2024
|
Kaitlyn Melanie Arsenault Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,206
-20.62%
|
$172,824
$4.99 P/Share
|
|
Nov 18
2024
|
Punit Dhillon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
82,546
-20.02%
|
$330,184
$4.99 P/Share
|
|
Nov 18
2024
|
Paul A. Grayson Director |
SELL
Open market or private sale
|
Direct |
86,244
-24.93%
|
$344,976
$4.99 P/Share
|
|
Nov 15
2024
|
Tuan Tu Diep Chief Development Officer |
SELL
Open market or private sale
|
Direct |
85
-0.08%
|
$425
$5.55 P/Share
|
|
Nov 15
2024
|
Kaitlyn Melanie Arsenault Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
190
-0.09%
|
$950
$5.55 P/Share
|
|
Nov 15
2024
|
Punit Dhillon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
364
-0.09%
|
$1,820
$5.55 P/Share
|
|
Nov 15
2024
|
Paul A. Grayson Director |
SELL
Open market or private sale
|
Direct |
307
-0.09%
|
$1,535
$5.55 P/Share
|